Brief: Lipocine Announces Positive LPCN 2401 Clinical Results
11/04/2024 12:09
April 11 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE ANNOUNCES POSITIVE LPCN 2401 CLINICAL RESULTS
SHOWING
IMPROVED BODY COMPOSITION IN PARTICIPANTS WITH OBESITY
* LIPOCINE INC: LPCN 2401 TREATMENT RESULTED IN
STATISTICALLY
SIGNIFICANT BODY COMPOSITION IMPROVEMENT IN MEN
* LIPOCINE INC: LPCN 2401 WELL-TOLERATED, ADVERSE EVENTS
(AES)
SIMILAR TO PLACEBO
Source text for Eikon: ID:nPn8zXNpga
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy